ArticleMolecular cancer2024
Patient-specific signaling signatures predict optimal therapeutic combinations for triple negative breast cancer.
Heba Alkhatib et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it